Limitless X Holdings Inc. Forms HealthMD Inc. to Drive Innovation, Accelerate Growth and Increase Shareholder Value in Wellness Sector
Limitless X Holdings (OTCQB: LIMX) has announced the formation of HealthMD Inc., a wholly-owned subsidiary focused on health and wellness innovation. This strategic expansion aims to complement LIMX's existing direct-to-consumer supplement business with AI-integrated technologies and holistic lifestyle solutions.
The initiative targets the $5.6 trillion global wellness market, with the U.S. market projected to exceed $2.4 trillion by 2027. HealthMD will operate at the intersection of wellness, AI healthcare (expected to reach $187 billion by 2030), and health technology (growing at 19.8% CAGR). The subsidiary is expected to drive revenue growth, achieve higher margins, and increase customer lifetime value through integrated wellness solutions.
Limitless X Holdings (OTCQB: LIMX) ha annunciato la creazione di HealthMD Inc., una controllata interamente posseduta focalizzata sull'innovazione nel settore della salute e del benessere. Questa espansione strategica mira a integrare l'attuale attività di LIMX nel settore degli integratori diretti al consumatore con tecnologie basate sull'intelligenza artificiale e soluzioni olistiche per lo stile di vita.
L'iniziativa si rivolge al mercato globale del benessere da 5,6 trilioni di dollari, con il mercato statunitense che si prevede supererà i 2,4 trilioni di dollari entro il 2027. HealthMD opererà all'intersezione tra benessere, sanità basata su AI (stimata raggiungere i 187 miliardi di dollari entro il 2030) e tecnologia sanitaria (con un tasso di crescita annuo composto del 19,8%). La controllata dovrebbe favorire la crescita dei ricavi, ottenere margini più elevati e aumentare il valore della vita del cliente attraverso soluzioni integrate di benessere.
Limitless X Holdings (OTCQB: LIMX) ha anunciado la creación de HealthMD Inc., una subsidiaria de propiedad total enfocada en la innovación en salud y bienestar. Esta expansión estratégica busca complementar el negocio existente de suplementos directos al consumidor de LIMX con tecnologías integradas de inteligencia artificial y soluciones holísticas para el estilo de vida.
La iniciativa apunta al mercado global de bienestar de 5.6 billones de dólares, con el mercado estadounidense proyectado para superar los 2.4 billones de dólares para 2027. HealthMD operará en la intersección del bienestar, la atención médica con IA (que se espera alcance los 187 mil millones de dólares para 2030) y la tecnología sanitaria (con un crecimiento anual compuesto del 19.8%). Se espera que la subsidiaria impulse el crecimiento de ingresos, logre mayores márgenes y aumente el valor de vida del cliente mediante soluciones integradas de bienestar.
Limitless X Holdings (OTCQB: LIMX)는 건강 및 웰니스 혁신에 중점을 둔 100% 자회사인 HealthMD Inc. 설립을 발표했습니다. 이번 전략적 확장은 LIMX의 기존 직접 소비자 대상 보충제 사업에 AI 통합 기술과 전체론적 라이프스타일 솔루션을 보완하는 것을 목표로 합니다.
이 사업은 5.6조 달러 규모의 글로벌 웰니스 시장을 겨냥하며, 미국 시장은 2027년까지 2.4조 달러를 초과할 것으로 예상됩니다. HealthMD는 웰니스, AI 헬스케어(2030년까지 1870억 달러 예상), 그리고 건강 기술(연평균 성장률 19.8%)의 교차점에서 운영될 예정입니다. 이 자회사는 통합된 웰니스 솔루션을 통해 매출 성장, 높은 마진 달성 및 고객 생애 가치를 증대시킬 것으로 기대됩니다.
Limitless X Holdings (OTCQB : LIMX) a annoncé la création de HealthMD Inc., une filiale entièrement détenue axée sur l'innovation en santé et bien-être. Cette expansion stratégique vise à compléter l'activité existante de LIMX dans les compléments alimentaires vendus directement aux consommateurs avec des technologies intégrant l'IA et des solutions de mode de vie holistiques.
L'initiative cible le marché mondial du bien-être de 5,6 trillions de dollars, le marché américain devant dépasser 2,4 trillions de dollars d'ici 2027. HealthMD opérera à l'intersection du bien-être, des soins de santé basés sur l'IA (prévu à 187 milliards de dollars d'ici 2030) et des technologies de la santé (croissant à un TCAC de 19,8%). Cette filiale devrait stimuler la croissance des revenus, atteindre des marges plus élevées et augmenter la valeur à vie des clients grâce à des solutions intégrées de bien-être.
Limitless X Holdings (OTCQB: LIMX) hat die Gründung von HealthMD Inc. bekannt gegeben, einer hundertprozentigen Tochtergesellschaft, die sich auf Innovationen im Bereich Gesundheit und Wellness konzentriert. Diese strategische Erweiterung soll das bestehende Direktvertriebs-Geschäft von LIMX für Nahrungsergänzungsmittel durch KI-integrierte Technologien und ganzheitliche Lebensstil-Lösungen ergänzen.
Die Initiative zielt auf den 5,6 Billionen Dollar schweren globalen Wellness-Markt ab, wobei der US-Markt bis 2027 voraussichtlich 2,4 Billionen Dollar übersteigen wird. HealthMD wird an der Schnittstelle von Wellness, KI-gestützter Gesundheitsversorgung (mit erwarteten 187 Milliarden Dollar bis 2030) und Gesundheitstechnologie (mit einem jährlichen Wachstum von 19,8%) operieren. Die Tochtergesellschaft soll das Umsatzwachstum fördern, höhere Margen erzielen und den Kundenlebenswert durch integrierte Wellness-Lösungen steigern.
- None.
- Operating in highly competitive wellness and health technology sectors
- Execution risks associated with technology integration and market expansion
LOS ANGELES, CA, July 15, 2025 (GLOBE NEWSWIRE) -- Limitless X Holdings, Inc. (OTCQB: LIMX), a leading force in the Health, Wellness, and Lifestyle sectors, is pleased to announce the registration and corporate filing of its wholly owned subsidiary, HealthMD Inc. This strategic expansion aligns with Limitless X’s mission to empower individuals through transformative wellness solutions that help them Look Good. Feel Great. Live Limitless.
HealthMD Inc. will serve as a growth accelerator for Limitless X, delivering a new suite of health-forward products, AI-integrated technologies, and holistic lifestyle solutions. The initiative builds on the Company’s existing operational strengths and is positioned to capitalize on rapidly expanding demand across the health and wellness industries, with a strong focus on long-term value creation and scalable innovation.
“HealthMD is not just an extension of what we’re doing. It is the next chapter in how we serve a global audience seeking sustainable, modern wellness,” said Jas Mathur, Chairman and CEO of Limitless X Holdings Inc. “We are combining our proven brand equity with forward-thinking technology to unlock opportunities that will redefine how people take charge of their health, confidence, and daily performance.”
COMPLEMENTING OUR DIRECT-TO-CONSUMER SUPPLEMENT STRATEGY
HealthMD Inc. will directly complement Limitless X’s existing Consumer Packaged Goods (CPG) division, which focuses on the direct-to-consumer sale of dietary supplements across key wellness verticals including energy, weight management, performance, beauty, and longevity. Together, these divisions will create a synergistic ecosystem that enables customers to access cohesive, lifestyle-driven wellness journeys powered by science, optimized by technology, and enhanced by experience.
By aligning HealthMD’s digital-first health innovations with the trusted supplement brands under the Limitless X umbrella, the Company aims to increase customer retention, maximize cross-sell potential, and strengthen long-term brand loyalty.
EXPANSION INTO A MULTI-TRILLION-DOLLAR ECOSYSTEM
HealthMD Inc. is launching at a pivotal time, as multiple macrotrends drive significant growth across adjacent industries:
- The global wellness market is now valued at over
$5.6 trillion , with the U.S. market alone projected to surpass$2.4 trillion by 2027. - More than 133 million Americans (approximately
40% of the population) suffer from chronic conditions such as diabetes, anxiety, obesity, and sleep disorders, contributing to over$4 trillion in annual healthcare costs. Many of these conditions are addressable through lifestyle, nutrition, and wellness interventions. - The AI healthcare market is expected to grow to more than
$187 billion globally by 2030, as consumers and providers increasingly adopt intelligent technologies to improve outcomes and personalize care. - The broader health technology sector is expanding at a compound annual growth rate (CAGR) of
19.8% , representing one of the most attractive sectors for innovation-led companies.
HealthMD is strategically positioned to operate at the intersection of these high-growth categories, offering consumers holistic wellness solutions that blend technology, lifestyle, and trusted products.
FOCUSED ON STRATEGIC GROWTH AND SHAREHOLDER VALUE
HealthMD Inc. is expected to contribute meaningfully to the financial outlook of Limitless X Holdings Inc. with the potential to:
- Drive top-line revenue growth through diversified offerings
- Achieve higher gross margins through technology-enhanced wellness products
- Increase customer lifetime value through integrated solutions
- Strengthen market positioning in wellness, consumer health, and AI-powered platforms
This initiative reflects Limitless X’s ongoing commitment to building enduring brand value, expanding its leadership position in the wellness industry, and delivering long-term returns to shareholders through disciplined innovation and strategic execution.
About Limitless X Holdings, Inc.
Limitless X Holdings, Inc. (OTCQB: LIMX) is building a dynamic, value-driven ecosystem designed to help individuals "Look Good and Feel Great" by integrating Health, Wellness, Entertainment, Community Building, and Brand Development. Through its wholly owned subsidiary, Limitless X, Inc., the company specializes in Direct-to-Consumer eCommerce, offering innovative products and services that empower people to reinvent themselves and become the best versions of themselves. The company has expanded into the Film and Television sector, with plans to develop and produce content that aligns with its core philosophy of "Feeling Great" and “Satisfied.” Limitless X also intends on expanding into the Real Estate industry by introducing High Performance Healthy Living; Residential communities and developments designed to promote wellness, longevity, and lifestyle optimization. Additionally, the company is expanding into Global Distribution and International Markets, aiming to bring its wellness-focused products and lifestyle brands to consumers worldwide. By leveraging advanced online marketing strategies, key relationships, and global reach, Limitless X is positioned to become a household name, delivering unmatched value to customers, driving long-term growth for shareholders, and fostering meaningful connections within communities around the world.
Media Contact:
media@limitlessx.com
Investor Relations Contact:
ir@limitlessx.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Statements regarding the benefits of Limitless Nootropic Blend Coffee Concentrate have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FAQ
What is HealthMD Inc. and how does it relate to Limitless X Holdings (LIMX)?
What is the market opportunity for Limitless X's HealthMD subsidiary?
How will HealthMD Inc. impact Limitless X's financial performance?
What is the strategic rationale behind Limitless X's formation of HealthMD?
What market trends is Limitless X (LIMX) targeting with HealthMD?
